Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011089457 - NOVEL MEDICINAL COMPOUNDS

Publication Number WO/2011/089457
Publication Date 28.07.2011
International Application No. PCT/HU2011/000009
International Filing Date 21.01.2011
IPC
C07D 471/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/519 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
A61K 31/5377 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61P 31/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
06for tuberculosis
CPC
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
A61P 31/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
06for tuberculosis
C07D 471/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Applicants
  • URATIM GYÁRTÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG [HU]/[HU] (AllExceptUS)
  • CSONKA, István [HU]/[HU] (UsOnly)
  • GROLMUSZ, Vince [HU]/[HU] (UsOnly)
  • RÉPÁSI, József [HU]/[HU] (UsOnly)
  • SZABADKA, Zoltán [HU]/[HU] (UsOnly)
  • SZABÓ, András [HU]/[HU] (UsOnly)
  • KERTÉSZ, Máriusz [HU]/[HU] (UsOnly)
Inventors
  • CSONKA, István
  • GROLMUSZ, Vince
  • RÉPÁSI, József
  • SZABADKA, Zoltán
  • SZABÓ, András
  • KERTÉSZ, Máriusz
Agents
  • KOVÁRI, Zoltán
Priority Data
P100003421.01.2010HU
Publication Language English (EN)
Filing Language Hungarian (HU)
Designated States
Title
(EN) NOVEL MEDICINAL COMPOUNDS
(FR) NOUVEAUX COMPOSÉS MÉDICINAUX
Abstract
(EN)
The present invention concerns novel compounds possessing the general formula (I), pharmaceutical preparations containing such active ingredients, as well as the process for manufacture thereof, where R, X, A and Q are defined in the claims. The novel compounds are efficient in the prevention and/or treatment of diseases caused by the bacterium Mycobacterium tuberculosis or any other Mycobacteria.
(FR)
L'invention concerne des nouveaux composés médicinaux représentés par la formule générale (I), des compositions pharmaceutiques de tels principes actifs ainsi que le procédé permettant de les fabriquer; R, X, A et Q étant tels que définis dans les revendications. Les nouveaux composés sont efficaces pour empêcher et/ou traiter des maladies provoquées par la bactérie Mycobacterium tuberculosis ou toute autre mycobactérie.
Latest bibliographic data on file with the International Bureau